Page last updated: 2024-10-29

isradipine and Syndrome

isradipine has been researched along with Syndrome in 2 studies

Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.

Syndrome: A characteristic symptom complex.

Research Excerpts

ExcerptRelevanceReference
" With the monotherapy of essential hypertension concurrent with hypercholesterolemia with the alpha 1-adrenoblocker Doxazosin, in addition to the agent's high antihypertensive effects, the authors noted its favourable action on lipid spectral parameters and platelet functional activity."3.69[Hypertension, diabetes mellitus, atherosclerosis: clinical manifestations of metabolic syndrome X. Prospects of pharmacological treatment]. ( Ivleva, AIa; Kobalava, ZhD; Moiseev, VS, 1995)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moiseev, VS1
Ivleva, AIa1
Kobalava, ZhD1
Prentice, DE1
Siegel, RA1
Donatsch, P1
Qureshi, S1
Ettlin, RA1

Other Studies

2 other studies available for isradipine and Syndrome

ArticleYear
[Hypertension, diabetes mellitus, atherosclerosis: clinical manifestations of metabolic syndrome X. Prospects of pharmacological treatment].
    Vestnik Rossiiskoi akademii meditsinskikh nauk, 1995, Issue:5

    Topics: Anticholesteremic Agents; Arteriosclerosis; Diabetes Mellitus; Diabetes Mellitus, Type 2; Doxazosin;

1995
Mesulergine induced Leydig cell tumours, a syndrome involving the pituitary-testicular axis of the rat.
    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement, 1992, Volume: 15

    Topics: Animals; Dihydropyridines; Ergolines; Isradipine; Leydig Cell Tumor; Male; Pituitary Hormones; Rats;

1992